Johan Haux

2.4k total citations
13 papers, 502 citations indexed

About

Johan Haux is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Johan Haux has authored 13 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Johan Haux's work include Colorectal Cancer Treatments and Studies (3 papers), Immune Cell Function and Interaction (3 papers) and Mass Spectrometry Techniques and Applications (3 papers). Johan Haux is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Immune Cell Function and Interaction (3 papers) and Mass Spectrometry Techniques and Applications (3 papers). Johan Haux collaborates with scholars based in Norway, Sweden and Denmark. Johan Haux's co-authors include Steinar Tretli, Olbjørn Klepp, Olav Spigset, Anders Sundan, Bjørg Steinkjer, Terje Espevik, Kjartan Egeberg, Andrei E. Medvedev, David H. Lynch and Avi Ashkenazi and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and BMC Cancer.

In The Last Decade

Johan Haux

13 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Haux Norway 9 292 146 103 57 47 13 502
Matthias Blumrich Germany 9 239 0.8× 114 0.8× 145 1.4× 39 0.7× 25 0.5× 12 496
Zhongzheng Lu China 11 392 1.3× 66 0.5× 121 1.2× 71 1.2× 20 0.4× 11 642
Hironori Kikkawa Japan 12 226 0.8× 54 0.4× 127 1.2× 55 1.0× 50 1.1× 23 418
Judith Leibovici Israel 15 318 1.1× 196 1.3× 238 2.3× 59 1.0× 12 0.3× 83 698
Shijie Fan China 12 299 1.0× 50 0.3× 96 0.9× 69 1.2× 21 0.4× 31 518
Pamela Rutherford United States 7 255 0.9× 60 0.4× 115 1.1× 42 0.7× 16 0.3× 8 402
Patricia Ambroziak United States 8 550 1.9× 66 0.5× 127 1.2× 47 0.8× 10 0.2× 8 706
Francis P. Barbone United States 14 323 1.1× 121 0.8× 134 1.3× 27 0.5× 8 0.2× 16 629
K Higashino Japan 6 241 0.8× 181 1.2× 33 0.3× 48 0.8× 20 0.4× 9 472
Suhlan Wu United States 11 356 1.2× 38 0.3× 158 1.5× 52 0.9× 14 0.3× 11 516

Countries citing papers authored by Johan Haux

Since Specialization
Citations

This map shows the geographic impact of Johan Haux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Haux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Haux more than expected).

Fields of papers citing papers by Johan Haux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Haux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Haux. The network helps show where Johan Haux may publish in the future.

Co-authorship network of co-authors of Johan Haux

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Haux. A scholar is included among the top collaborators of Johan Haux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Haux. Johan Haux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Labori, Knut Jørgen, Svein Olav Bratlie, Christina Biörserud, et al.. (2023). Short-course neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer: A multicenter randomized phase-II trial (NORPACT-1).. Journal of Clinical Oncology. 41(17_suppl). LBA4005–LBA4005. 28 indexed citations
4.
Carlsson, Göran, Tormod Kyrre Guren, Johan Haux, et al.. (2018). ISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer. Annals of Oncology. 29. viii190–viii190. 1 indexed citations
6.
Moxnes, John F., Johan Haux, & Kjell Hausken. (2004). The dynamics of cell proliferation. Medical Hypotheses. 62(4). 556–563. 6 indexed citations
7.
Haux, Johan. (2002). Digitalis; impinges on more than just the (ion-) pump. Medical Hypotheses. 59(6). 781–782. 10 indexed citations
8.
Haux, Johan, Olbjørn Klepp, Olav Spigset, & Steinar Tretli. (2001). Digitoxin medication and cancer; case control and internal dose-response studies. BMC Cancer. 1(1). 11–11. 124 indexed citations
10.
Haux, Johan, et al.. (1999). The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosis. Cancer Immunology Immunotherapy. 48(2-3). 139–146. 19 indexed citations
11.
Haux, Johan. (1999). Digitoxin is a potential anticancer agent for several types of cancer. Medical Hypotheses. 53(6). 543–548. 135 indexed citations
12.
Haux, Johan, Bjørg Steinkjer, Unni Nonstad, et al.. (1999). REGULATION OF APO-2 LIGAND/TRAIL EXPRESSION IN NK CELLS—INVOLVEMENT IN NK CELL-MEDIATED CYTOTOXICITY. Cytokine. 11(9). 664–672. 66 indexed citations
13.
Medvedev, Andrei E., Johan Haux, Bjørg Steinkjer, et al.. (1997). REGULATION OF FAS AND FAS-LIGAND EXPRESSION IN NK CELLS BY CYTOKINES AND THE INVOLVEMENT OF FAS-LIGAND IN NK/LAK CELL-MEDIATED CYTOTOXICITY. Cytokine. 9(6). 394–404. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026